- Home
- ACHV vs AFBI Comparison
ACHV vs AFBI Comparison
Compare ACHV & AFBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- AFBI
- Stock Information
- Founded
- ACHV N/A
- AFBI 1928
- Country
- ACHV Canada
- AFBI United States
- Employees
- ACHV N/A
- AFBI N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AFBI Major Banks
- Sector
- ACHV Health Care
- AFBI Finance
- Exchange
- ACHV Nasdaq
- AFBI Nasdaq
- Market Cap
- ACHV 159.0M
- AFBI 140.1M
- IPO Year
- ACHV N/A
- AFBI N/A
- Fundamental
- Price
- ACHV $4.98
- AFBI $21.25
- Analyst Decision
- ACHV Strong Buy
- AFBI
- Analyst Count
- ACHV 4
- AFBI 0
- Target Price
- ACHV $15.50
- AFBI N/A
- AVG Volume (30 Days)
- ACHV 112.5K
- AFBI 7.2K
- Earning Date
- ACHV 11-07-2024
- AFBI 11-01-2024
- Dividend Yield
- ACHV N/A
- AFBI N/A
- EPS Growth
- ACHV N/A
- AFBI N/A
- EPS
- ACHV N/A
- AFBI 0.84
- Revenue
- ACHV N/A
- AFBI $30,152,000.00
- Revenue This Year
- ACHV N/A
- AFBI N/A
- Revenue Next Year
- ACHV N/A
- AFBI N/A
- P/E Ratio
- ACHV N/A
- AFBI $25.27
- Revenue Growth
- ACHV N/A
- AFBI N/A
- 52 Week Low
- ACHV $3.03
- AFBI $13.76
- 52 Week High
- ACHV $5.98
- AFBI $21.98
- Technical
- Relative Strength Index (RSI)
- ACHV 56.44
- AFBI 39.24
- Support Level
- ACHV $4.85
- AFBI $21.17
- Resistance Level
- ACHV $5.13
- AFBI $21.44
- Average True Range (ATR)
- ACHV 0.18
- AFBI 0.12
- MACD
- ACHV -0.01
- AFBI -0.03
- Stochastic Oscillator
- ACHV 43.40
- AFBI 22.22
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, and residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.